Literature DB >> 16467361

Semaphorin 3d guides laterality of retinal ganglion cell projections in zebrafish.

Jill A Sakai1, Mary C Halloran.   

Abstract

The optic chiasm is an important choice point at which retinal ganglion cell (RGC) axons either cross the midline to innervate the contralateral brain or turn back to innervate the ipsilateral brain. Guidance cues that regulate this decision, particularly those directing the midline crossing of contralateral axons, are still not well understood. Here we show that Sema3d, a secreted semaphorin expressed at the midline, guides the crossing of RGC axons in zebrafish. Both Sema3d knockdown and ubiquitous overexpression induced aberrant ipsilateral projections, suggesting that Sema3d normally guides axons into the contralateral optic tract. Live imaging in vivo showed that RGC growth cones responded to ubiquitous Sema3d overexpression by pausing for extended periods and increasing their exploratory behavior at the midline, suggesting that Sema3d overexpression causes the midline environment to become less favorable for RGC axon extension. Interestingly, Sema3d overexpression did not affect growth cone behaviors before the midline, suggesting that RGC axons normally respond to Sema3d only upon reaching the midline. After Sema3d knockdown, growth cones grew across the midline but then paused or repeatedly retracted, impairing their ability to leave the midline region. Our results indicate that a proper balance of Sema3d is needed at the midline for the progression of RGC axons from the chiasm midline into the contralateral optic tract.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16467361     DOI: 10.1242/dev.02272

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  24 in total

Review 1.  Cellular strategies of axonal pathfinding.

Authors:  Jonathan Raper; Carol Mason
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-30       Impact factor: 10.005

2.  The calmodulin-stimulated adenylate cyclase ADCY8 sets the sensitivity of zebrafish retinal axons to midline repellents and is required for normal midline crossing.

Authors:  Hong Xu; Sarah G Leinwand; Alison L Dell; Emma Fried-Cassorla; Jonathan A Raper
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

Review 3.  Reconnecting Eye to Brain.

Authors:  Michael C Crair; Carol A Mason
Journal:  J Neurosci       Date:  2016-10-19       Impact factor: 6.167

4.  Mical links semaphorins to F-actin disassembly.

Authors:  Ruei-Jiun Hung; Umar Yazdani; Jimok Yoon; Heng Wu; Taehong Yang; Nidhi Gupta; Zhiyu Huang; Willem J H van Berkel; Jonathan R Terman
Journal:  Nature       Date:  2010-02-11       Impact factor: 49.962

5.  VEGF shows its attractive side at the midline.

Authors:  Travis L Dickendesher; Roman J Giger
Journal:  Neuron       Date:  2011-06-09       Impact factor: 17.173

Review 6.  Extracellular inhibitors, repellents, and semaphorin/plexin/MICAL-mediated actin filament disassembly.

Authors:  Ruei-Jiun Hung; Jonathan R Terman
Journal:  Cytoskeleton (Hoboken)       Date:  2011-08-25

7.  cAMP-induced expression of neuropilin1 promotes retinal axon crossing in the zebrafish optic chiasm.

Authors:  Alison L Dell; Emma Fried-Cassorla; Hong Xu; Jonathan A Raper
Journal:  J Neurosci       Date:  2013-07-03       Impact factor: 6.167

8.  Retinal ganglion cell axon sorting at the optic chiasm requires dystroglycan.

Authors:  Reena Clements; Kevin M Wright
Journal:  Dev Biol       Date:  2018-08-24       Impact factor: 3.582

9.  Sema4C expression in neural stem/progenitor cells and in adult neurogenesis induced by cerebral ischemia.

Authors:  Haitao Wu; Jundie Fan; Lingling Zhu; Shuhong Liu; Yan Wu; Tong Zhao; Yanrui Wu; Xuefeng Ding; Wenhong Fan; Ming Fan
Journal:  J Mol Neurosci       Date:  2009-02-03       Impact factor: 3.444

10.  Zebrafish zic2a patterns the forebrain through modulation of Hedgehog-activated gene expression.

Authors:  Nicholas A Sanek; Aaron A Taylor; Molly K Nyholm; Yevgenya Grinblat
Journal:  Development       Date:  2009-11       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.